Patent · US Active

Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections

US9993469B2 · kind B2 · utility

2Cited by

0References

14Claims

0Family size

Assignee

Morphochem Aktiengesellschaft Für Kombinatorische Chemie · DE

Inventors

Thomas Kapsner · Drolshagen, DE
Axel Dalhoff · Wuppertal, DE

Key dates

Filing date	May 28, 2014
Grant date	Jun 12, 2018
Priority date	—
Expiry date	May 28, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a combination of at least one oxazolidinone-quinolone hybrid with at least one further antibacterial compound and the use thereof as drug, especially for the treatment or prophylaxis of bacterial infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.